Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins

被引:59
作者
Parkin, ET
Hussain, I
Karran, EH
Turner, AJ
Hooper, NM [1 ]
机构
[1] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[2] SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England
基金
英国惠康基金;
关键词
Alzheimer's disease; presenilins; detergent-insoluble domains; cytoskeleton; cerebral cortex; proteolytic fragments;
D O I
10.1046/j.1471-4159.1999.721534.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many cases of early-onset familial Alzheimer's disease have been linked to mutations within two genes encoding the proteins presenilin-1 and presenilin-2. The presenilins are 48-56-kDa proteins that can be proteolytically cleaved to generate an N-terminal fragment (similar to 25-35 kDa) and a C-terminal fragment (similar to 17-20 kDa). The N- and C-terminal fragments of presenilin-1, but not full-length presenilin-1, were readily detected in both human and mouse cerebral cortex and in neuronal and glioma cell lines, in contrast, presenilin-2 was detected almost exclusively in cerebral cortex as the full-length molecule with a molecular mass of 56 kDa. The association of the presenilins with detergent-insoluble, low-density membrane microdomains, following the isolation of these structures from cerebral cortex by solubilization in Triton X-100 and subsequent sucrose density gradient centrifugation, was also examined. A minor fraction (10%) of both the N- and C-terminal fragments of presenilin-1 was associated with the detergent-insoluble, low-density membrane microdomains, whereas a considerably larger proportion of full-length presenilin-2 was present in the same membrane microdomains. in addition, a significant proportion of full-length presenilin-2 was present in a high-density, detergent-insoluble cytoskeletal pellet enriched in beta-actin. The presence of the presenilins in detergent-insoluble low-density membrane microdomains indicates a possible role for these specialized regions of the membrane in the lateral separation of Alzheimer's disease-associated proteins within the lipid bilayer and/or in the distinct functions of these proteins.
引用
收藏
页码:1534 / 1543
页数:10
相关论文
共 50 条
  • [31] Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro
    Morinaga, Akiyoshi
    Ono, Kenjiro
    Takasaki, Junichi
    Ikeda, Tokuhei
    Hirohata, Mie
    Yamada, Masahito
    EXPERIMENTAL NEUROLOGY, 2011, 228 (02) : 298 - 302
  • [32] From Association to Intervention: The Alzheimer's Disease-Associated Processes and Targets (ADAPT) Ontology
    Daly, Timothy
    Henry, Vincent
    Bourdenx, Mathieu
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 : S87 - S96
  • [33] Alterations in Alzheimer's Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients
    Li, Hsueh-Yu
    Tsai, Ming-Shao
    Huang, Chung-Guei
    Wang, Robert Y. L.
    Chuang, Li-Pang
    Chen, Ning-Hung
    Liu, Chi-Hung
    Hsu, Cheng-Ming
    Cheng, Wen-Nuan
    Lee, Li-Ang
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [34] PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia
    Justin Rustenhoven
    Amy M. Smith
    Leon C. Smyth
    Deidre Jansson
    Emma L. Scotter
    Molly E. V. Swanson
    Miranda Aalderink
    Natacha Coppieters
    Pritika Narayan
    Renee Handley
    Chris Overall
    Thomas I. H. Park
    Patrick Schweder
    Peter Heppner
    Maurice A. Curtis
    Richard L. M. Faull
    Mike Dragunow
    Molecular Neurodegeneration, 13
  • [35] Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults
    Maruyama, Takuma
    Wada, Harmony
    Abe, Yoichiro
    Niikura, Takako
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 500 (02) : 470 - 475
  • [36] PU.1 regulates Alzheimer's disease-associated genes in primary human microglia
    Rustenhoven, Justin
    Smith, Amy M.
    Smyth, Leon C.
    Jansson, Deidre
    Scotter, Emma L.
    Swanson, Molly E. V.
    Aalderink, Miranda
    Coppieters, Natacha
    Narayan, Pritika
    Handley, Renee
    Overall, Chris
    Park, Thomas I. H.
    Schweder, Patrick
    Heppner, Peter
    Curtis, Maurice A.
    Faull, Richard L. M.
    Dragunow, Mike
    MOLECULAR NEURODEGENERATION, 2018, 13
  • [37] Alzheimer's disease-associated complement gene variants influence plasma complement protein levels
    Veteleanu, Aurora
    Stevenson-Hoare, Joshua
    Keat, Samuel
    Daskoulidou, Nikoleta
    Zetterberg, Henrik
    Heslegrave, Amanda
    Escott-Price, Valentina
    Williams, Julie
    Sims, Rebecca
    Zelek, Wioleta M.
    Carpanini, Sarah M.
    Morgan, Bryan Paul
    JOURNAL OF NEUROINFLAMMATION, 2023, 20 (01)
  • [38] Prediction of Alzheimer's Disease-Associated Genes by Integration of GWAS Summary Data and Expression Data
    Hao, Sicheng
    Wang, Rui
    Zhang, Yu
    Zhan, Hui
    FRONTIERS IN GENETICS, 2019, 9
  • [39] Spinosin Attenuates Alzheimer's Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity
    Cai, Mudan
    Jung, Inho
    Kwon, Huiyoung
    Cho, Eunbi
    Jeon, Jieun
    Yun, Jeanho
    Lee, Young Choon
    Kim, Dong Hyun
    Ryu, Jong Hoon
    BIOMOLECULES & THERAPEUTICS, 2020, 28 (02) : 131 - 136
  • [40] Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease)
    A D Roses
    A M Saunders
    Y Huang
    J Strum
    K H Weisgraber
    R W Mahley
    The Pharmacogenomics Journal, 2007, 7 : 10 - 28